ezetimibe has been researched along with Aortic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al Kindi, M; Al Rasadi, K; Al Waili, K; Aljenedil, S; Awan, Z; Bélanger, AM; Genest, J; Ruel, I; Sayegh, K; Senouci, S; Sivakumaran, L; Valenti, D | 1 |
| Atrott, K; Bourayou, R; Dietrich, T; Fleck, E; Graf, K; Gräfe, M; Hucko, T; Jahnke, C; Klein, C; Paetsch, I; Schnackenburg, B; Stawowy, P | 1 |
2 other study(ies) available for ezetimibe and Aortic Diseases
| Article | Year |
|---|---|
Aortic Calcification Progression in Heterozygote Familial Hypercholesterolemia.
Topics: Aged; Anticholesteremic Agents; Aorta; Aortic Diseases; Calcium; Cholesterol, LDL; Ezetimibe; Female; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Male; Middle Aged; Receptors, LDL; Tomography, X-Ray Computed; Vascular Calcification | 2017 |
High resolution magnetic resonance imaging in atherosclerotic mice treated with ezetimibe.
Topics: Animals; Anticholesteremic Agents; Aorta, Thoracic; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Azetidines; Body Weight; Cholesterol; Disease Models, Animal; Ezetimibe; Magnetic Resonance Angiography; Mice; Mice, Inbred C57BL; Mice, Knockout; Reproducibility of Results; Time Factors | 2009 |